Overall rank by patents
#11,218
of 50,000 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Cognyte Technologies Israel Ltd.
USPTO PatentsView assignee record - 27 granted patents across 9 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
27
Total patents granted
9
CPC technology areas
16.9
Avg claims per patent
-
5-year grant velocity
The verdict
According to USPTO PatentsView, Cognyte ranks #11,218 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 9 technology areas.
- #11,218
- of 50,000 US assignees by volume
- Top 10%
- by Innovation Score (52.3/100)
- 16.9
- avg claims per patent
Portfolio overview
Cognyte Technologies Israel Ltd. has been granted 27 US utility patents between 2022 and 2025, placing Cognyte Technologies Israel Ltd. at #11,218 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.9 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a Foreign Corporation, Cognyte Technologies Israel Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cognyte sits between Champ Vision Display Inc. (27 patents, rank #11,202) and Casper Sleep Inc. (27 patents, rank #11,210) - the closest US assignees by grant volume. The composite Innovation Score of 52.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2022 through 2025, with 27 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Cognyte Technologies Israel Ltd.'s 16.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 9 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Who files at Cognyte's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Champ Vision Disp…
CHAMP VISION DISPLAY INC.
27 patents
- Chaoyang Semicond…
CHAOYANG SEMICONDUCTOR JIANGYIN TECHNOLOGY CO., LTD.
27 patents
- Clearside Biomedi…
CLEARSIDE BIOMEDICAL, INC.
27 patents
- Co2pac
CO2PAC Limited
27 patents
- Coperion
COPERION GMBH
27 patents
- CPT Group
CPT Group GmbH
27 patents
- Crinetics Pharmac…
CRINETICS PHARMACEUTICALS, INC.
27 patents
- Casper Sleep
Casper Sleep Inc.
27 patents
- Cognyte Israel ◀
COGNYTE TECHNOLOGIES ISRAEL LTD.
27 patents
What this shows Cognyte holds 27 patents at rank #11,206, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cognyte
By rank, the assignees closest to #11,206 in granted patent volume.
- Champ Vision Display Inc. #11,202 · 27 patents
- Chaoyang Semiconductor Jiangyin Technology Co., Ltd. #11,203 · 27 patents
- Clearside Biomedical, Inc. #11,204 · 27 patents
- Co2pac Limited #11,205 · 27 patents
- Coperion Gmbh #11,207 · 27 patents
- CPT Group Gmbh #11,208 · 27 patents
- Crinetics Pharmaceuticals, Inc. #11,209 · 27 patents
- Casper Sleep Inc. #11,210 · 27 patents
Leaders in H04L (Transmission OF Digital Information)
Other assignees with the most granted patents in Cognyte's primary technology class.
- International Business Machines Corporation 15,969 in class
- Qualcomm Incorporated 13,594 in class
- Huawei Technologies Co., Ltd. 11,697 in class
- Samsung Electronics Co., Ltd. 10,543 in class
- LG Electronics Inc. 9,062 in class
- Telefonaktiebolaget LM Ericsson (publ) 8,543 in class
- Cisco Technology, Inc. 7,502 in class
- Microsoft Technology Licensing, Llc 7,301 in class
Cognyte's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 17 | 63.0% |
| 2023 | 4 | 14.8% |
| 2024 | 4 | 14.8% |
| 2025partial year | 2 | 7.4% |
Which technologies does Cognyte Technologies Israel Ltd. patent most?
Top 9 of 9 technology areas
Grant record at a glance
Portfolio Volume 27 grants
CPC subclasses 9
Avg. claims / grant 16.9
Historical grant data only; it does not rate legal strength or current strategy.
Frequently Asked Questions
Where does Cognyte Technologies Israel Ltd. rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), Cognyte Technologies Israel Ltd. ranks #11,218 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does Cognyte Technologies Israel Ltd. hold?
Cognyte Technologies Israel Ltd. holds 27 US utility patents granted between 2022 and 2025, spanning 9 technology areas.
What is Cognyte Technologies Israel Ltd.'s Innovation Score?
Cognyte Technologies Israel Ltd. has an Innovation Score of 52.3 out of 100 (top 10% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cognyte Technologies Israel Ltd. focus on?
Cognyte Technologies Israel Ltd.'s top technology area is H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION) with 21 patents. Grants appear in 9 CPC subclasses total.
Is Cognyte Technologies Israel Ltd.'s patent grant rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Cognyte Technologies Israel Ltd..
What does claim depth mean for Cognyte Technologies Israel Ltd.'s patents?
Cognyte Technologies Israel Ltd.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the Cognyte Technologies Israel Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Cognyte's 27 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Cognyte ranks #11,218 of 50,000. Top 50 holders
- Most of this portfolio concentrates in H04L - see who else leads that technology area. H04L leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.